Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender

Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender

An obvious trend of the last decade in head and neck squamous cell carcinoma pathogenesis evaluation is awareness of the impact of immune response disorders on disease manifestation. The review presents an analysis of the differences in the type and degree of immunosuppression, as well as treatment...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. I. Stukan, R. A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov, V. A. Porkhanov
Format:	Article
Language:	Russian
Published:	ABV-press 2022-12-01
Series:	Опухоли головы и шеи
Subjects:	adaptive immune response head and neck squamous cell carcinoma cd4+ t-lymphocytes cd8+ t-lymphocytes immunosuppressive factors gender differences human papillomavirus status
Online Access:	https://ogsh.abvpress.ru/jour/article/view/820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma
by: Kengo Shigehara, et al.
Published: (2025-07-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01)

Comparative morphological characteristics for stable and progressive pulmonary tuberculoma
by: Natalia E. Gimaldinova, et al.
Published: (2025-04-01)

CD4/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: a retrospective study
by: Thibaut Zannese, et al.
Published: (2025-05-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
by: M. N Khorobrykh, et al.
Published: (2014-07-01)

EXPRESSION OF SURFACE MARKERS ON CD4+T-LYMPHOCYTES IN NORMAL PREGNANCY AND PRE-ECLAMPSIA
by: V. A. Mikhailova, et al.
Published: (2014-07-01)

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction
by: A. I. Stukan, et al.
Published: (2024-04-01)

Functional analysis of fibroblasts and macrophages in head and neck paragangliomas
by: Paramita Baruah, et al.
Published: (2024-11-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

ROLE OF THE CELLULAR IMMUNITY IN THE PATHOGENESIS OF BRAIN CONTUSION
by: A. O. Norka, et al.
Published: (2021-10-01)

Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma
by: Hiroki Komatsuda, et al.
Published: (2025-06-01)

The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
by: A. V. Ignatova, et al.
Published: (2024-06-01)

Treatment of chronic lymphocytic leukaemia and autoimmune complications with antibody targeted to the CD52 antigen (Campath) - the first Russian experience
by: T. E. Byalik, et al.
Published: (2022-11-01)

Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
by: Devadarssen Murdamoothoo, et al.
Published: (2021-05-01)

CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19
by: D. Torres-Gonzales, et al.
Published: (2025-07-01)

Human papillomavirus in head and neck cancer (literature review)
by: A. M. Pevzner, et al.
Published: (2019-07-01)

Natural killer cell granule protein 7 contributes to CD8+ T cell-mediated platelet apoptosis in immune thrombocytopenia
by: Xiaolin Wang, et al.
Published: (2025-07-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF HIV-INFECTION IN DYNAMICS AGAINST THE BACKGROUND OF ANTIRETROVIRAL THERAPY AMONG PATIENTS IN POLTAVA REGION
by: O.H. Marchenko, et al.
Published: (2019-12-01)

The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment
by: Ikhwan Rinaldi
Published: (2018-06-01)

Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112
by: Ruth Soler-Agesta, et al.
Published: (2025-12-01)

Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders
by: Yaping Chu, et al.
Published: (2025-08-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markers
by: Saira Hamid, et al.
Published: (2025-05-01)

Analysis of the diagnostic value of NLR and PLR in cervical lymph node metastasis of tongue squamous cell carcinoma before surgery
by: CHENG Longlong, et al.
Published: (2024-12-01)

Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
by: Yu. V. Alymov, et al.
Published: (2023-09-01)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
by: Zi Mei, et al.
Published: (2020-01-01)

The role of receptor-mediated T-cells activation disorders in pulmonary tuberculosis
by: Irina E. Esimova, et al.
Published: (2017-07-01)

Investigating age-related dynamics and transcriptional signatures of CD8<sup>+</sup>HLA-DR<sup>+</sup> regulatory T lymphocytes: perspectives in understanding immune system aging
by: K. S. Matveeva, et al.
Published: (2024-09-01)

Clinical value of HIV-1 matched detection in patients’ blood and cerebrospinal fluid
by: E. V. Stepanova, et al.
Published: (2014-09-01)

Expression features of CD16 and NKG2D receptors by NK cells, NKT cells and T lymphocytes of peripheral blood associated with female infertility
by: V. A. Mikhailova, et al.
Published: (2025-07-01)

COMMUNITY-ACQUIRED PNEUMONIA IN HIV-INFECTED SUBJECTS: MICROFLORA, ANTIBIOTIC RESISTANCE: DEPENDENCE ON THE LEVELS OF CD4 LYMPHOCYTES
by: D. N. Akusheva, et al.
Published: (2019-07-01)

Prognostic analysis of 1 026 patients with head and neck squamous cell carcinoma based on SEER database
by: LI Qian, et al.
Published: (2023-08-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

ROLE OF CYTOXIC T-LYMPHOCYTES IN THE PATHOGENESIS OF PRETERM BIRTH
by: N. R. Radzhabova, et al.
Published: (2021-10-01)

Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy
by: A. I. Stukan, et al.
Published: (2022-04-01)

The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
by: Ruoyi Yang, et al.
Published: (2024-11-01)

DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study
by: Chao Tan, et al.
Published: (2025-08-01)

OPTIMAL TREATMENT STRATEGY FOR PATIENTS WITH PROGRESSIVE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: L. V. Bolotina, et al.
Published: (2019-09-01)